Starpharma Holdings Ltd. (OTCMKTS:SPHRY) Short Interest Update

Starpharma Holdings Ltd. (OTCMKTS:SPHRY) saw a large increase in short interest in August. As of August 14th, there was short interest totaling 101 shares, an increase of ∞ from the July 30th total of 0 shares. Based on an average trading volume of 796 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the stock are short sold.

Starpharma Price Performance

Shares of Starpharma stock remained flat at $5.30 on Monday. The stock had a trading volume of 100 shares, compared to its average volume of 501. Starpharma has a one year low of $0.73 and a one year high of $5.70. The company has a fifty day moving average of $4.89 and a 200 day moving average of $4.39.

Starpharma Company Profile

Starpharma is a clinical-stage biopharmaceutical company specializing in the development of dendrimer-based products across infectious disease, oncology and ophthalmology. Its proprietary dendrimer platform, DEP™ (Dendrimer Enhanced Products), enables precise molecular engineering to enhance drug delivery, targeting and safety profiles. The company’s lead product, VivaGel®, is a topical microbicide that has been approved in multiple markets for the treatment and prevention of bacterial vaginosis and is in clinical development for antiviral applications.

In addition to VivaGel, Starpharma is advancing pipeline candidates that leverage DEP technology to improve the performance of established and novel therapeutic agents.